Clinical Study Initiation

Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate
KalVista Shares Climb As Late-Stage Label Extension Study On Skin Disorder Candidate Kicks-off
ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off
KalVista Shares Climb As Late-Stage Label Extension Study On Skin Disorder Candidate Kicks-off
ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off
Pfizer And Valneva Commence Late-Stage Lyme Disease Study
Astria Therapeutics Commences Initial-Stage Skin Disorder Study, Sees Preliminary Data By Year-end

Clinical Study Initiation Recent News

Aytu BioPharma Commences Late-Stage Genetic Disorder Study
Aytu BioPharma (NASDAQ: AYTU) has initiated the global Phase 3 PREVEnt clinical trial of Enzastaurin (AR101) for the treatment of patients with COL3A1-positive Vascular Ehlers-Danlos Syndrome (VEDS).
Edgewise Therapeutics Initiates Mid-Stage Muscular Dystrophies Study
Edgewise Therapeutics (NASDAQ: EWTX) announced the initiation of the CANYON Phase 2 clinical trial evaluating EDG-5506 in individuals with Becker Muscular Dystrophy (BMD).
Corcept Therapeutics Commences Late-Stage Ovarian Cancer Study
Corcept Therapeutics (NASDAQ: CORT) has initiated pivotal Phase 3 clinical trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer.
Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection
Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced Initiation of Phase 1b clinical study of its drug candidate ABI-H3733 for Chronic Hepatitis B Virus Infection